Ledger.Open graph →
SEC Form D · filed August 22, 2024

Indaptus Therapeutics, Inc

Offering
$205K
Sold
$205K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Mark J. Gilbert · NEW YORK, NYDirectorMichael J. Newman · NEW YORK, NYExec · DirectorNir A. Sassi · NEW YORK, NYExecWilliam B. Hayes · NEW YORK, NYDirectorRoger J. Waltzman · NEW YORK, NYExecWalt A. Linscott · NEW YORK, NYExecAnthony J. Maddaluna · NEW YORK, NYDirectorJeffrey A. Meckler · NEW YORK, NYExec · DirectorHila J. Karah · NEW YORK, NYDirectorRoger J. Pomerantz · NEW YORK, NYDirectorRobert E. Martell · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗